i'm gonna number your points and my responses for clarity:
1) i agree with you about responsibility falling on parents and doctors.
2) i also agree that doctors are too easily manipulated by the reps of pharma companies, and by general public hysteria...which can also be augmented by ignorant medical boards when AAS are involved.
3) common sense isn't always common.
4) i disagree, black box warnings are used when the FDA gets reports of serious side effects and the FDA feels those side effects are under-appreciated among doctors and patients...whether it's the risk of tendon rupture with flouroquinolones like Cipro, excessive bleeding on Warfarin, actually dying of cancer from Tacrolimus, or causing hormonal disruptions in children and women via t-gels.
5) i never made that accusation, and take your assertion of warning of t-gel side effects at face value. However, i do think that fighting the black box warning in this case is a losing battle, and if you appeared on a news program with some frothing anti-AAS activist giving counterpoint, i suspect THEY would milk the "you don't care about children" angle, and any moderating host would have to ask you "c'mon, where's the real harm in just warning people?"
6) i expect that there probably are cases of children applying their parent's t-gel directly, but i doubt that accounts for all cases...and i suspect not all cases of children exposed to adverse levels of t-gel have even come to the FDA's attention. Most coverage of hormone disruptions in children have focused on the substantial variability in response form child to child, whether it's from medically supervised hormone therapy or from aggregate exposure to things like xenoestrogens in livestock and dairy products producing morphological disruptions like premature menstruation in girls and feminizing effects in boys.
of course i also wouldn't be surprised if there was the occasional parent stupid enough to make their children use such medication, whihc would of course be abuse. in any case, I'd imagine the FDA running through a few of these scenarios (and points 1-3) and deciding that a black box warning couldn't possibly hurt and might help.
7) actually i'd expect the FDA to consider controlled-substance labels and other warning labels applied to med-bottles at a pharmacy sufficient in most circumstances...ironically, overall anti-drug hysteria better serves their purpose in that regard than a black box warning could. it may very well be that Androgel's and Testim's successful marketing as safer" and less offensive than injectable T was a critical factor in getting the FDA to issue the black warning as a caveat.
anyway, i'm still curious if your animus against this move is purely procedural ("black box warnings are not supposed to be used THAT way!") or if you think this warning could/will serve as a pretext for more overall restriction and enforcement...
thanks for the thorough response btw, and my noobie-howdies to your Admin-highness.